BrainsWay Investor Relations Material
Latest events
Q1 2025
BrainsWay
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BrainsWay Ltd
Access all reports
Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. The company offers Deep TMS device that uses magnetic current pulses to stimulate the brain safely and painlessly; and Deep TMS Coil that is attached to the dTMS device. It markets the BrainsWay Deep TMS system under the hElios brand name for treating various psychiatric and neurological disorders. Brainsway Ltd. has a license agreement with InSightec, Ltd., which is a co-owner of the exclusive license issued by the Technion-Israel Institute of Technology. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
Latest articles
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
Ticker symbol
BWAY
Country
🇺🇸 United States